Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Zebra 365 who wrote (2288)	11/10/1997 9:01:00 AM
From: Zebra 365	Read Replies (2) \| Respond to of 23519

New published info on Viagra The Medical Tribune, Nov 6, 1997 This is a Medical tabloid put out by the New York Post and is not a peer-reviewed medical journal. But it is out there, distributed to physicians free of charge, and this blurb is pertinent. The November issue is out in print but not at the web site: medtrib.com (below is transcribed verbatim from print issue) Impotence Pill Found Effective by Ed Susman MADRID, Spain --- An experimental oral drug can help impotent men acheive erections sufficient to allow sexual intercourse, investigators reported here last month at a meeting of the European Society of Impotence Research. While many procedures are available to assist men in achieving an erection, there has been no sucessful oral treatment for impotence. William Steers, M.D., of the University of Virginia in Charlottesville, found in a study involving 58 patients with severe erectile dysfunction that the drug sildenafil produced a satisfactory response in 40% to 59% of the men, depending on the dosage of the drug. Almost 75% of the men in the study had organic erectile dysfunction associated with high blood pressure, diabetes or other factors. During the eight-week study, the men took the oral dose of sildenafil an hour before planning sexual intercourse. Depending on the dose, 40% to 59% of the men were able to acheive an erection judged sufficient for intercourse, compared with 10% to 13% of patients receiving placebo. The researchers said the study shows that sildenafil "is an effective, well-tolerated oral treatment of erectile dysfunction." Self-injection into the penis shaft with the drug alprostadil can produce erections in 90% or more of cases involving organic impotence. However patients and partners of patients are often wary of injections. In the sildenafil study the researchers did not find any major side effects. The study was funded by Pfizer, the manufacturer of sildenafil. In September, Pfizer applied to the U.S. Food and Drug Administration for approval of the drug, which would be marketed under the name Viagra. Note no mention of the MUSE as an alternative. Post on clinical use of the drugs: exchange2000.com Well, posted for your information. Also a copy to BigKNY3 for the Peabody Report. Zebra